di Reumatologia, Società Italiana, trans. 2025. “CO:11:5 | Laboratory Preliminary Results from an Open Label, Prospective, Phase Ii Descriptive Pilot Trial of Belimumab Therapy for Refractory and Or Non Criteria Manifestations of Antiphospholipid Syndrome: Alice Barinotti1, Massimo Radin1, Irene Cecchi1, Beatrice Ala1, Chiara Raymondi1, Elena Rubini1, Silvia G. Foddai1, Lois Ira Maniulit Capulong1, Alessio Conti1, Alessandro Morotti1, Dario Roccatello1, Roberta Fenoglio1, Savino Sciascia1. | 1Università Di Torino, Italy”. Reumatismo 77 (s1). https://doi.org/10.4081/reumatismo.2025.1997.